(Q34778803)

English

Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties (English)

1 reference

Europe PubMed Central

4 August 2017

author name string

Karin R Tietje

1

1 reference

Europe PubMed Central

4 August 2017

David J Anderson

2

1 reference

Europe PubMed Central

4 August 2017

R Scott Bitner

3

1 reference

Europe PubMed Central

4 August 2017

Eric A Blomme

4

1 reference

Europe PubMed Central

4 August 2017

Paul J Brackemeyer

5

1 reference

Europe PubMed Central

4 August 2017

Clark A Briggs

6

1 reference

Europe PubMed Central

4 August 2017

Kaitlin E Browman

7

1 reference

Europe PubMed Central

4 August 2017

Dagmar Bury

8

1 reference

Europe PubMed Central

4 August 2017

Peter Curzon

9

1 reference

Europe PubMed Central

4 August 2017

Karla U Drescher

10

1 reference

Europe PubMed Central

4 August 2017

Jennifer M Frost

11

1 reference

Europe PubMed Central

4 August 2017

Ryan M Fryer

12

1 reference

Europe PubMed Central

4 August 2017

Gerard B Fox

13

1 reference

Europe PubMed Central

4 August 2017

Jens Halvard Gronlien

14

1 reference

Europe PubMed Central

4 August 2017

Monika Håkerud

15

1 reference

Europe PubMed Central

4 August 2017

Earl J Gubbins

16

1 reference

Europe PubMed Central

4 August 2017

Sabine Halm

17

1 reference

Europe PubMed Central

4 August 2017

Richard Harris

18

1 reference

Europe PubMed Central

4 August 2017

Rosalind J Helfrich

19

1 reference

Europe PubMed Central

4 August 2017

Kathy L Kohlhaas

20

1 reference

Europe PubMed Central

4 August 2017

Devalina Law

21

1 reference

Europe PubMed Central

4 August 2017

John Malysz

22

1 reference

Europe PubMed Central

4 August 2017

Kennan C Marsh

23

1 reference

Europe PubMed Central

4 August 2017

Ruth L Martin

24

1 reference

Europe PubMed Central

4 August 2017

Michael D Meyer

25

1 reference

Europe PubMed Central

4 August 2017

Angela L Molesky

26

1 reference

Europe PubMed Central

4 August 2017

Arthur L Nikkel

27

1 reference

Europe PubMed Central

4 August 2017

Stephani Otte

28

1 reference

Europe PubMed Central

4 August 2017

Liping Pan

29

1 reference

Europe PubMed Central

4 August 2017

Pamela S Puttfarcken

30

1 reference

Europe PubMed Central

4 August 2017

Richard J Radek

31

1 reference

Europe PubMed Central

4 August 2017

Holly M Robb

32

1 reference

Europe PubMed Central

4 August 2017

Eva Spies

33

1 reference

Europe PubMed Central

4 August 2017

Kirsten Thorin-Hagene

34

1 reference

Europe PubMed Central

4 August 2017

Jeffrey F Waring

35

1 reference

Europe PubMed Central

4 August 2017

Hilde Ween

36

1 reference

Europe PubMed Central

4 August 2017

Hongyu Xu

37

1 reference

Europe PubMed Central

4 August 2017

Murali Gopalakrishnan

38

1 reference

Europe PubMed Central

4 August 2017

William H Bunnelle

39

1 reference

Europe PubMed Central

4 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

4 August 2017

CNS Neuroscience & Therapeutics

1 reference

Europe PubMed Central

4 August 2017

14

1 reference

Europe PubMed Central

4 August 2017

1

1 reference

Europe PubMed Central

4 August 2017

65-82

1 reference

Europe PubMed Central

4 August 2017

Molecular psychology: roles for the ERK MAP kinase cascade in memory

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Schizophrenia, sensory gating, and nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

[3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

PSAB-OFP, a selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Antisense knockdown of the rat alpha7 nicotinic acetylcholine receptor produces spatial memory impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Nicotinic acetylcholine receptors and the regulation of neuronal signalling.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Mal de Meleda (MDM) caused by mutations in the gene for SLURP-1 in patients from Germany, Turkey, Palestine, and the United Arab Emirates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Nicotinic acetylcholine receptor subtypes involved in facilitation of GABAergic inhibition in mouse superficial superior colliculus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Effects of histamine H(3) receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Neuronal nicotinic receptors: from structure to pathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

A two-year study on the effects of nicotine and its withdrawal on mood and sleep

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Targeting the cholinergic system as a therapeutic strategy for the treatment of pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

The cholinergic system in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Poor Tolerability of a Transdermal Nicotine Treatment in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Presynaptic ionotropic receptors and the control of transmitter release.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Medicinal chemical properties of successful central nervous system drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

The -2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Predictive, non-GLP models of secondary pharmacodynamics: putting the best compounds forward

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Drug-induced prolongation of the QT interval

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Nicotinic receptors in the development and modulation of CNS synapses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Central nicotinic receptors: structure, function, ligands, and therapeutic potential.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

(R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Lipophilicity in PK design: methyl, ethyl, futile

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity rela

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Presynaptic nicotinic ACh receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00037.X

21 January 2018

Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18482100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of cisplatin- and m-chlorophenylbiguinide-induced emesis in ferrets

1 reference

https://pubmed.ncbi.nlm.nih.gov/18482100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18482100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of blood-brain barrier penetration: are we missing the point?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18482100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulators of nicotinic acetylcholine receptors as analgesics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18482100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18482100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1755-5949.2008.00037.X

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34778803&oldid=1954279372"